Ilika Plc Leading the Charge in Solid-State Battery Innovation, Panmure Liberum note ‘Considerable Upside’

IKA

Ilika Plc (LON:IKA) continues to demonstrate progress in the rapidly evolving battery technology market. With its latest milestone, the successful testing of the Goliath D5 prototype, the company solidifies its position at the forefront of solid-state battery development. This achievement highlights the potential of Ilika’s innovative solutions to provide a safer, lighter, and more cost-effective alternative to conventional lithium-ion batteries, particularly for electric vehicles (EVs).

The Goliath D5 prototype builds on the success of previous iterations by optimising the cell architecture to enhance its safety features without compromising energy density. Lacie Midgley, Research Analyst at Panmure Liberum, notes, “This morning’s successful testing announcement reconfirms the benefits of Goliath relative to lithium-ion (li-ion) equivalent across a number of key variables.” She further emphasises that the test results confirm the potential of Ilika’s cells to provide superior battery solutions for EVs, with lighter, safer, and faster-charging capabilities.

A New Benchmark for Safety

Ilika’s D5 prototype outperformed expectations during rigorous safety testing, with notable results such as a 300°C lower failure temperature compared to lithium-ion cells in Accelerated Rate Calorimetry testing by the University of Oxford. Additionally, the D5 cells passed the nail penetration test, conducted by University College London (UCL), with flying colours—external temperatures remained below 80°C, and the cells did not catch fire or explode, as would typically occur with traditional lithium-ion batteries under such conditions.

This superior safety performance allows EV designers to reduce the amount of mechanical protection needed, ultimately leading to lighter vehicles and lower manufacturing costs. As Midgley points out, “This enables lighter and less expensive EV designs that have a longer range for the same amount of energy.”

Industry Support and Future Outlook

Adding to the excitement, Ilika’s Goliath batteries received recognition from industry heavyweight BYD, the world’s largest maker of new energy vehicles. At the World New Energy Vehicle Congress, BYD publicly supported solid-state batteries as part of the future EV transport mix. This endorsement signals growing confidence in the technology and highlights the increasing relevance of Ilika’s advancements on the global stage.

Looking ahead, Ilika is set to continue its development trajectory towards D8 and Minimum Viable Product (MVP) samples, which remain on track for 2025. The company’s progress aligns with its strategic goals, promising future licensing opportunities with Tier 1 companies and original equipment manufacturers (OEMs). With a projected target price of 70p, Panmure Liberum reiterates its BUY recommendation for Ilika shares, offering significant upside potential.

On a Final Note

Ilika’s commitment to innovation and safety in the battery market is clearly paying off. The company’s Goliath D5 prototype is a game-changer, paving the way for safer and more efficient electric vehicles. With continued advancements and strong industry backing, Ilika is poised to become a key player in the future of sustainable transport.

Share on:
Find more news, interviews, share price & company profile here for:

    Latest Company News

    Ilika’s Stereax batteries set for Medical Technology Ireland showcase

    Ilika’s Stereax batteries will be showcased by Cirtec Medical at Medical Technology Ireland, giving the company targeted exposure in the medical device market.

    Ilika CEO Graeme Purdy discusses Stereax revenues and Goliath opportunities

    Ilika CEO Graeme Purdy discusses first Stereax revenues, grant support for Goliath, EV market trends, and opportunities in defence and e-bikes.

    Ilika positions solid state batteries for the future of implantable neurostimulation

    Ilika’s Stereax solid state battery technology supports the development of smaller, safer and more practical implantable neurostimulation devices for emerging medical applications.

    Ilika advances manufacturing readiness for solid-state batteries

    Ilika’s collaboration with UKBIC shows how manufacturing validation is helping move its Goliath pouch cell technology closer to commercial readiness.

    Ilika reports first Stereax revenues and Goliath progress

    Ilika expects FY26 revenue of approximately £1.1m, including first commercial Stereax electrode sales, with Goliath evaluation activity expanding across automotive, defence and e-bike applications.

    Search